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Abstract
Background: Sarcoidosis is a rare condition that is often misdiagnosed as malignant tumors due to the similar
clinical manifestations and imaging findings.
Case Presentation: We encountered a 56-year-old Chinese woman who had a chief complaint of a persistent cough.
The chest computer tomography (CT) revealed mediastinal and bilateral hilar lymph node enlargement, and positron
emission tomography-computer tomography (PET-CT) revealed abnormal fluorodeoxyglucose (FDG) uptake in the
lymph nodes of the chest and abdomen. To further clarify the diagnosis, a lymph node sampling was performed by
video-assisted thoracoscopic surgery (VATS) and the histopathologic diagnosis of sarcoidosis was confirmed.
Conclusions: VATS could be an effective and minimally invasive diagnostic method to discriminate pulmonary
sarcoidosis with other malignant tumors.
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Background
Sarcoidosis is an uncommon disease of unknown eti-
ology that is characterized by the presence of noncaseat-
ing granulomas [1]. Sarcoidosis affects people of all
racial and ethnic groups and occurs at all ages, although
it usually develops before the age of 50 years, with the
incidence peaking at 20 to 39 years [2]. Sarcoidal granu-
lomas can involve any organ, but in more than 90 % of
patients, clinical sarcoidosis is manifested as intratho-
racic lymph node enlargement, pulmonary involvement,
skin or ocular signs and symptoms, or some combin-
ation of these findings [3]. Systemic symptoms such as
fatigue, night sweats, and weight loss are common. Sar-
coidosis patients may be misdiagnosed with tuberculosis,
lymphoma, or lung cancer [4]. The diagnosis of sarcoid-
osis is established on the basis of compatible clinical and
radiologic findings, supported by histologic evidence in
one or more organs of noncaseating epithelioid-cell
granulomas in the absence of organisms or particles.
Case presentation
A 56-year-old Chinese woman was admitted with cough
and expectoration (white phlegm) for 1 month. These
symptoms developed without apparent cause and in the
absence of other problems, such as chest pain and/or
distress, breathlessness, fever, hemoptysis, nausea, or
vomiting. She denied the presence of any chronic disor-
ders and smoking and had no family history of cancers.
An enhanced chest computed tomography (CT) scan
imaged a right hilar mass and a small amount of bilat-
eral pleural effusions, accompanied with the enlargement
of multiple lymph nodes in the mediastinal and bilateral
hilar areas, as shown in Fig. 1. The blood tests and urin-
alysis on admission were within normal limits. To assist
the diagnosis of the mass, a panel of tumor biomarkers,
including CEA (carcino-embryonic antigen), NSE
(neuron-specific enolase), SCC (squamous cell carcin-
oma), and CYFRA21-1 (cytokeratin 19 fragments),
were tested. Only an upregulated level of NSE was
observed (19.94 μg/L, normal reference value 0–
16.3 μg/L). Bronchoscopic exam did not reveal any
abnormality, and a transbronchial biopsy by endo-
bronchial ultrasound guided transbronchial needle as-
piration (EBUS-TBNA) did not found collections of
malignant cells either. A body fluorodeoxyglucose
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(FDG) positron emission tomography-computer tom-
ography (PET-CT) demonstrated remarkably increased
FDG uptake in the hilus of the right lung, accompanied by
multiple lymph node enlargements in bilateral hilar areas,
mediastinum, and abdomen (Fig. 2). Therefore, the diag-
nosis of malignant tumors was preliminarily made.
To further clarify the diagnosis, a subcarinal lymph
node resection was performed by right-sided video-
assisted thoracoscopic (VATS). In brief, a 40-mm inci-
sion was made in the fifth intercostal space of the right
anterior axillary line for the instrumental operation. A
30-degree 10 mm high definition thoracoscope was
employed through the seventh intercostal space of the
right mid-axillary line. It was observed from the thoraco-
scope that mediastinal lymph nodes were diffusely en-
larged, and lymph node biopsy was applied by a
harmonic scalpel. As shown in Fig. 3, histopathologic
examination was granulomatous lesions and a diagnosis
of sarcoidosis was confirmed. After the postoperative re-
covery, the patient was transferred to the respiratory de-
partment to receive further medication treatment.
Discussion
Sarcoidosis is a multisystemic disorder of unknown eti-
ology that is characterized by the presence of noncaseat-
ing granulomas and the proliferation of epithelioid cells
[1]. Sarcoidosis can involve multiple organs; the lungs
and lymph node are the most frequently involved or-
gans. The cause and pathogenesis are unknown; how-
ever, a number of etiologies have been proposed in
recent years, primarily based on genetic and immuno-
logic factors [5]. The diagnosis of sarcoidosis is com-
monly established based on clinical and radiologic
findings that are supported by histologic findings. The
diagnosis of sarcoidosis is often delayed for various rea-
sons, mainly due that the imaging is not suggestive
sometimes. A study from Brazil evaluated 100 patients
with a biopsy-proven diagnosis of sarcoidosis. The
median number of physicians consulted was 3 (range, 1–
14), and the diagnosis of sarcoidosis was timely in 41
patients and delayed in 59 [6]. The typical radiologic
findings associated with sarcoidosis include symmetric,
bilateral hilar, and paratracheal lymphadenopathy, with
or without concomitant parenchymal abnormalities.
However, in 25–30 % of cases, the radiologic findings
are atypical, which causes difficulty in making a correct
diagnosis [7]. Atypical forms of intrathoracic sarcoidosis
have been described as unilateral or asymmetric lymph-
adenopathy, necrosis or cavitation, large opacity, ground
glass opacity, airway abnormality, pleural involvement,
and the reversed halo sign [7–9]. A better understanding
of the radiologic manifestations of sarcoidosis is very
helpful for making a correct diagnosis. In addition, we
observed that NSE, a well-known tumor marker for neu-
roendocrine tumors, was upregulated a bit in this case.
Given the radiological image and the upregulated value
of NSE, the diagnosis of small cell lung cancer was ever
considered before the biopsy of VATS. However, the
Fig. 1 CT scans of the chest. An enhanced chest CT scans indicated
a right hilar mass and multiple lymph node enlargements in the
mediastinal and bilateral hilar areas of the lungs (white arrows), as
well as bilateral small pleural effusions (red arrows)
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final pathological diagnosis did not support our specula-
tion, indicating that sarcoidosis may be misdiagnosed
with other malignant tumors if only tumor markers were
considered.
In recent years, PET-CT has become a superior means
of diagnosis of sarcoidosis. Moreover, 18F-FDG PET has
been proven to be a very useful imaging technique in
diagnosis, disease activity assessment, monitoring treat-
ment response, and risk assessment in patients with sar-
coidosis [10]. In suspected or known sarcoidosis
patients, PET-CT may be useful in the evaluation of dis-
ease extent and monitoring treatment response [11]. In
atypical, complex, and multisystem sarcoidosis, PET-CT
plays an important role for the evaluation of the
localization and effect of treatment [12]. Although it has
so many advantages, PET-CT can cause many false-
positive and its role in the diagnosis of sarcoidosis is
limited [13]. Pleural effusion is rare in patients with pul-
monary sarcoidosis. Only about 2.8–5 % of these pa-
tients exhibit pleural effusion [14–16]. A pleural effusion
in patients with sarcoidosis should not be assumed to be
related to sarcoidosis [16]. Pleural effusion in sarcoidosis
is often an exudate. The most common cause of exuda-
tive pleural effusion in elderly patients is a malignant
tumor or tuberculosis. Sarcoidosis is hard to be differen-
tiated with the two diseases. In this patient, the CT scan
showed a right hilar mass and a small amount of bilat-
eral pleural effusions, accompanied with the enlargement
of multiple lymph nodes in the mediastinal and bilateral
hilar areas, while PET-CT indicated a high FDG uptake
Fig. 3 Histopathological diagnosis. The routine H&E staining proved a diagnosis of sarcoidosis with granuloma plus Langhans giant cells (white arrows)
Fig. 2 PET-CT scan. PET-CT revealed abnormal FDG uptake in the lymph nodes of the upper mediastinum and bilateral hilar areas of the lungs
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in these lesions. The pathological diagnosis of sarcoid-
osis was determined after a video-assisted thoracoscopic
procedure. Timely and correct diagnosis is very import-
ant for improving pulmonary function and determining
the presence of lesions in other organs, while delayed
diagnosis is often associated with an impaired lung func-
tion and medication induced impairment of the other
organs [6]. For example, many sarcoidosis patients are
misdiagnosed with tuberculosis and treated with anti-
tuberculosis drugs who eventually developed with liver
function impairment. In addition, some serious forms of
sarcoidosis, such as cardiac sarcoidosis, can appear un-
detected because of the lack of systematic investigation
[6]. For these reasons, the diagnosis of sarcoidosis
should be promptly determined in order to avoid treat-
ment delay. Surgical intervention is an important modal-
ity for the attainment of a biopsy. VATS could be used
as a valid minimally invasive method for the diagnosis of
sarcoidosis, as it allows larger samples of tissue and
greater diagnostic yield. Furthermore, in comparison
with the traditional open techniques, VATS offers less
postoperative pain, a more rapid recovery, and much less
complications [17, 18].
Conclusions
In conclusion, sarcoidosis is difficult to be differentiated
with other malignant tumors by radiological and PET-
CT examinations. VATS biopsy is a minimally invasive,
safe, and effective procedure in the diagnosis of pulmon-
ary sarcoidosis.
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